The future of deep phenotyping in osteoarthritis: How can high throughput omics technologies advance our understanding of the cellular and molecular taxonomy of the disease?

Osteoarthritis (OA) is the most common form of musculoskeletal disease with significant healthcare costs and unmet needs in terms of early diagnosis and treatment. Many of the drugs that have been developed to treat OA failed in phase 2 and phase 3 clinical trials or produced inconclusive and ambigu...

Descripción completa

Detalles Bibliográficos
Autores principales: Mobasheri, Ali, Kapoor, Mohit, Ali, Shabana Amanda, Lang, Annemarie, Madry, Henning
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Virtual Special Issue on: Omics Phenotyping; Edited by Mohit Kapoor, AliMobasheri, Shabana Amanda Ali and Annemarie Lang
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9718223/
https://www.ncbi.nlm.nih.gov/pubmed/36474763
http://dx.doi.org/10.1016/j.ocarto.2021.100144

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9718223/
https://www.ncbi.nlm.nih.gov/pubmed/36474763
http://dx.doi.org/10.1016/j.ocarto.2021.100144

Ejemplares similares